327 related articles for article (PubMed ID: 35976963)
1. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.
Xie W; Zheng F; Zhong B; Song X
J Am Heart Assoc; 2015 Aug; 4(8):e002259. PubMed ID: 26304937
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.
Del Giovane C; Boncoraglio GB; Bertù L; Banzi R; Tramacere I
BMC Neurol; 2021 Aug; 21(1):319. PubMed ID: 34399713
[TBL] [Abstract][Full Text] [Related]
4. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
Yang C; Qian J; Tang X; Gao P; Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
[TBL] [Abstract][Full Text] [Related]
8. P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack.
Li ZX; Xiong Y; Gu HQ; Fisher M; Xian Y; Johnston SC; Wang YJ
Stroke; 2021 Jul; 52(7):2250-2257. PubMed ID: 34039032
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
Condello F; Liccardo G; Ferrante G
Curr Pharm Des; 2021; 27(40):4140-4146. PubMed ID: 34323179
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis.
Zitikyte G; Roy DC; Dhaliwal S; Lun R; Hutton B; Shorr R; Dowlatshahi D
PLoS One; 2021; 16(4):e0250553. PubMed ID: 33909676
[TBL] [Abstract][Full Text] [Related]
14. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dual versus mono antiplatelet therapy in patients with stroke or transient ischemic attack: An updated meta-analysis of 18 randomized controlled trials.
Fu-Sang W; Xiao-Han Z; Yang Z; Ting-Ting C; Chao S; Jing-Yi L; Jian-Jun Z
Pharmazie; 2020 Oct; 75(10):516-523. PubMed ID: 33305729
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
Malloy RJ; Kanaan AO; Silva MA; Donovan JL
Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
Marinheiro G; Araújo B; Monteiro GA; Leite M; Mutarelli A; Almeida AM; Cavalcante-Neto JF; Rivera A; Pinheiro AC; Telles JPM
J Neurol; 2024 Jun; 271(6):3030-3038. PubMed ID: 38580815
[TBL] [Abstract][Full Text] [Related]
18. Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis.
Albay CEQ; Leyson FGD; Cheng FC
BMC Neurol; 2020 Jun; 20(1):224. PubMed ID: 32493229
[TBL] [Abstract][Full Text] [Related]
19. Aspirin plus clopidogrel
Ye MB; Chen YL; Wang Q; An J; Ye F; Jing P
Scand Cardiovasc J; 2019 Aug; 53(4):169-175. PubMed ID: 31112048
[No Abstract] [Full Text] [Related]
20. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
